Sign up to save your podcasts
Or
Share NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.
Joshua Barocas is an associate professor of medicine at the University of Colorado Anschutz Medical Campus. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.A. Barocas. The Erosion of Harm Reduction. N Engl J Med 2025;393:1865-1867. B.A. Barsky, A. Caplan-Bricker, and C. Robertson. Religious Liberty as a Shield for Public Health — The Case of Overdose-Prevention Centers. N Engl J Med 2025;393:1867-1869.
View all episodes
By NEJM Group
4.4
120120 ratings
Joshua Barocas is an associate professor of medicine at the University of Colorado Anschutz Medical Campus. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.A. Barocas. The Erosion of Harm Reduction. N Engl J Med 2025;393:1865-1867. B.A. Barsky, A. Caplan-Bricker, and C. Robertson. Religious Liberty as a Shield for Public Health — The Case of Overdose-Prevention Centers. N Engl J Med 2025;393:1867-1869.
More shows like NEJM Interviews
View all
JAMA Editors' Summary
141 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
499 Listeners
JACC This Week
168 Listeners
Clinical Conversations
56 Listeners
Mayo Clinic Talks
297 Listeners
BMJ Best Practice Podcast
22 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
135 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
Curbside Consults
89 Listeners
Leadership Conversations
5 Listeners
Annals On Call Podcast
193 Listeners
JAMA Medical News
92 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners
The Curious Clinicians
374 Listeners
NEJM AI Grand Rounds
58 Listeners
Intention to Treat
31 Listeners
Not Otherwise Specified
65 Listeners